Predictors of Response to Autologous Dendritic Cell Therapy in Glioblastoma Multiforme
/in Dendritic Cells, Glioblastoma, International Publications /von 2018-05-29 / Front Immunol 2018;9:727First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
/in Dendritic Cells, Glioblastoma, International Publications /von 2018-05-29 / J Transl Med 2018 May;16(1):142Dendritic cells loaded with the lysate of tumor cells infected with Newcastle Disease Virus trigger potent anti-tumor immunity by promoting the secretion of IFN-γ and IL-2 from T cells
/in Dendritic Cells, International Publications, Newcastle Disease Virus /von 2018-05-22 / Oncol Lett 2018 Jul;16(1):1180-1188Pilot study of WT1 peptide-pulsed dendritic cell vaccination with docetaxel in esophageal cancer
/in Dendritic Cells, Esophageal Carcinoma, International Publications /von 2018-05-17 / Oncol Lett 2018 Jul;16(1):1348-1356Vaccine therapy in hematologic malignancies
/in Dendritic Cells, International Publications /von 2018-05-04 / Blood 2018 Jun;131(24):2640-2650IOZK Vortrag: Modulierte Elektro-Hyperthermie bei Kindern mit DIPG, Konferenz der ESHO, Charité Berlin
/in IOZK bei Fachtagungen, IOZK Meldungen /von IOZKInitial phase I/IIa trial results of an autologous tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine in patients with solid tumors
/in Dendritic Cells, International Publications /von 2018-05-01 / Vaccine 2018 05;36(23):3247-3253Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2018-05-01 / Ann. Oncol. 2018 May;29(5):1312-1319
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de